A new article published in the Zoonoses journal on June 12 highlights that tuberculosis remains a major infectious disease contributing to global mortality, with India accounting for a significant portion of the worldwide burden.
The report outlines that, despite notable advancements in diagnosis and treatment within India, several obstacles persist. These include drug-resistant tuberculosis, HIV co-infection, and significant gaps in private sector regulation that impede comprehensive disease control efforts.
India's approach to TB control has evolved over time. The transition from the Revised National Tuberculosis Control Program to the current National Tuberculosis Elimination Program marks a strategic move from focusing on disease control toward aiming for elimination. These initiatives have resulted in improved case detection rates and better treatment outcomes.
However, operational issues, infrastructural shortcomings, and socioeconomic barriers continue to present challenges. The article reviews recent developments in India's TB strategies while emphasizing both achievements and persistent difficulties faced by public health authorities.
The publication also examines global TB programs and assesses how the COVID-19 pandemic has affected notification rates and access to treatment for tuberculosis patients. It concludes by highlighting future directions necessary for India to meet its TB elimination targets.
